Showing 1 - 10 of 341
This paper reports the results from a statistical analysis of pharmaceutical price negotiations in Germany, where the … pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012119750
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we … construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic … producer and retail level. In the empirical analysis, we find a strong relationship between the margins of brand-names and …
Persistent link: https://www.econbiz.de/10009691207
find that prices have a negative impact on transitions in the sense that an increase in the brand price will reduce the … transition from generics to brand and likewise an increase in the generic price will reduce the transition from brand to generics … cholesterol. The two brand-name products on the Norwegian markets were Provachol (atc code C10AA03) and Zocor (atc code C10AA01 …
Persistent link: https://www.econbiz.de/10008697144
natural policy experiment in Norway, to what extent the price responsiveness of prescription choices is affected when the … structural model for the three drugs, covering demand and price setting, is estimated in a joint maximum likelihood approach. We … national insurance. -- pharmaceuticals ; discrete choice model ; funding-schemes …
Persistent link: https://www.econbiz.de/10009377790
explains large price heterogeneities across buyers, drug classes, and time periods. Additionally, of the drug price variation … transaction volume, buyer's loyalty, and multiple drug purchases strengthens buyer's bargaining power and results in a drug price …
Persistent link: https://www.econbiz.de/10012138768
-quality product and limits the wholesale price a brand manufacturer can charge. If, however, the branded product is not available … price is salient in the store, this aligns the retailer's incentives with the brand manufacturer's interest to make quality …We provide an explanation for a frequently observed vertical restraint in ecommerce, namely that brand manufacturers …
Persistent link: https://www.econbiz.de/10011717196
Millions of people refuse COVID-19 vaccination. Using original data from two surveys in nine OECD countries, we analyze the determinants of anti-vax intentions in December 2020 and show that half of the anti-vax individuals were vaccinated by summer 2021. Vaccinations were more likely among...
Persistent link: https://www.econbiz.de/10012815771
Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a … crucial question in designing health systems. This paper addresses this question by examining how price expectations shape the … the impact of price interdependencies and potential firm strategies in launch and pricing decisions. The empirical …
Persistent link: https://www.econbiz.de/10009127576
medicines conflicts with traditional sources of arbitrage (e.g., price and income differences) and instead is a form of … regulation, and not by price differences in line with the hypothesis of "regulatory arbitrage". …
Persistent link: https://www.econbiz.de/10010477153
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...
Persistent link: https://www.econbiz.de/10011406575